JOURNAL ARTICLE
Tech CEO Bryan Johnson says he'll make humans immortal by 2039—first he just needs to sort out 'buggy' issues like 'mistakenly causing cancer'.
Published In: Fortune.com, 2025. P. N.PAG 1 of 3
Database: Business Source Ultimate 2 of 3
Authored By: Royle, Orianna Rosa 3 of 3
Abstract
The article focuses on Bryan Johnson's ambitious goal to achieve human immortality by 2039, driven by advancements in therapies and artificial intelligence. Johnson, a Silicon Valley entrepreneur known for his previous ventures including Braintree and Kernel, is investing millions annually in anti-aging treatments and using his own body as a test subject for his research. He is exploring biological mechanisms linked to longevity, such as jellyfish cells and lobster enzymes, while also cloning his organs to facilitate drug testing. Johnson's rigorous daily routine includes extensive physical exercise, a strict diet, and continuous health monitoring, which he plans to share with the public to promote healthier living. [Extracted from the article]
Additional Information
- Source:Fortune.com. 2025/12, pN.PAG
- Document Type:Article
- Subject Area:Biology
- Publication Date:2025
- Accession Number:190329269
- Copyright Statement:Copyright of Fortune.com is the property of Fortune Media (USA) Corporation and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Looking to go deeper into this topic? Look for more articles on EBSCOhost.